GridAI Technologies (GRDX) Assets Average (2016 - 2026)
GridAI Technologies' (GRDX) quarterly Assets Average came in at $42.8 million in Q2 2026, down 49.73% on a YoY basis from $85.1 million in Q2 2025, and down 53.47% quarter-over-quarter from $92.0 million in Q4 2025.
Analysis
GridAI Technologies (GRDX) Assets Average (2016 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Assets Average for 11 consecutive years, with $42.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average fell 49.73% year-over-year to $42.8 million; the trailing twelve-month figure through Jun 2026 stood at $42.8 million (down 49.73% YoY), and the FY2025 full-year result was $67.0 million, up 45.15% from the prior year.
- Assets Average slipped to $42.8 million in Q2 2026 per GRDX's latest filing, from $92.0 million in the prior quarter.
- Across five years, Assets Average topped out at $110.2 million in Q3 2025 and bottomed at $4.3 million in Q3 2022.
- Historically, Assets Average has averaged $45.5 million across 5 years, with a median of $42.8 million in 2026.
- The sharpest annual moves came in 2022 and 2024: Assets Average sank 67.28% in 2022, then jumped 1699.07% in 2024.
- Over 5 years, Assets Average stood at $5.0 million in 2022, then gained by 27.02% to $6.4 million in 2023, then soared by 1236.64% to $85.6 million in 2024, then gained by 7.41% to $92.0 million in 2025, then slumped by 53.47% to $42.8 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $42.8 million, $92.0 million, and $110.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 94.07 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 52.82 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 26.95 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 41.30 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 11.22 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 30.78 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 5.51 Bn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | 42.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.79 Mn |
| Dec 31, 2025 | 91.96 Mn |
| Sep 30, 2025 | 110.21 Mn |
| Jun 30, 2025 | 85.13 Mn |
| Mar 31, 2025 | 85.31 Mn |
| Dec 31, 2024 | 85.62 Mn |
| Sep 30, 2024 | 86.05 Mn |
| Jun 30, 2024 | 88.71 Mn |
| Mar 31, 2024 | 49.01 Mn |
| Dec 31, 2023 | 6.41 Mn |
| Sep 30, 2023 | 5.13 Mn |
| Jun 30, 2023 | 4.93 Mn |
| Mar 31, 2023 | 5.49 Mn |
| Dec 31, 2022 | 5.04 Mn |
| Sep 30, 2022 | 4.29 Mn |
| Jun 30, 2022 | 6.38 Mn |
| Mar 31, 2022 | 10.31 Mn |
| Dec 31, 2021 | 12.11 Mn |
| Sep 30, 2021 | 13.10 Mn |
| Jun 30, 2021 | 15.88 Mn |